IP Library › Patent Application 14527669
Patent Application
App. No. 14/527,669

IMMUNOGEN PLATFORM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/527,669
Abstract

Aspects of the present invention relate to chimeric polypeptides including HCV NS3/4A sequences and T-cell epitopes. Embodiments include nucleic acids encoding the chimeric NS3/4A polypeptides, the encoded polypeptides, compositions containing said nucleic acids, compositions containing said chimeric polypeptides, as well as methods of making and using the aforementioned compositions including, but not limited to medicaments and vaccines.

Claims (2)

1 . An immunogenic composition comprising:

an isolated nucleic acid encoding a peptide immunogen that comprises a heterologous hepatitis C virus (HCV) NS3 protease cleavage site joined to an antigenic peptide at a position that is not naturally occurring.

Assignments (2)
SECURITY INTEREST Recorded Sep 29, 2015
From: TRIPEP AB
To: KNOBBE, MARTENS, OLSON & BEAR, LLP
Reel/Frame 036714/0719 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2014
From: CHRONTECH PHARMA AB
To: TRIPEP AB
Reel/Frame 034521/0261 →